PKUAI next meeting Wednesday 15th May, 7.30pm Clayton Hotel Leopardstown
We are delighted to let you know that at this meeting we will be joined by Dr Cary Harding* from America, one of the world’s leading experts on PKU. Please join us to hear him speak about how PKU is treated in America and what the future might hold.
We will also be discussing the recent news on Kuvan’s HSE approval, the LTI scheme and much more.
ALL WELCOME. If you plan on attending please RSVP to email@example.com
*Dr. Harding is an Associate professor in the Departments of Molecular and Medical Genetics and Pediatrics at Oregon Health & Science University (OHSU). He is board certified in pediatrics, clinical genetics, and biochemical genetics. He received his medical degree from the University of Washington followed by pediatric and medical genetics training at the University of Wisconsin-Madison. Dr. Harding is a founding fellow of the American College of Medical Genetics. He is an attending physician on the OHSU clinical genetics service, the clinical genetics clinic, and the metabolic clinic at Doernbecher Children’s Hospital and the medical director of the biochemical genetics laboratory in the Knight Diagnostic Laboratories at OHSU. He is also a clinical consultant to the Northwest Regional Newborn Screening Program and to the State of Idaho Genetics Program. Dr. Harding’s basic and clinical research programs are focused upon the development of novel therapies, including gene and cell therapies, for inborn errors of metabolism.